FDA Drug Recalls
1,463 recalls · Class I, newest first
Class I · High risk Terminated Jun 27, 2022
Reason Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment…
Class I · High risk Terminated Jun 27, 2022
Reason Subpotent and Superpotent Drug
Class I · High risk Terminated Jun 17, 2022
Reason Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets…
Class I · High risk Terminated Jun 17, 2022
Reason Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets…
Class I · High risk Terminated Jun 13, 2022
Reason Microbial Contamination of a Non-Sterile Products: Testing of product onfirmed the presence of Gluconacetobacter Liquefaciens
Class I · High risk Terminated Jun 10, 2022
Reason Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and dexamethasone.
Class I · High risk Terminated Jun 9, 2022
Reason Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia…
Class I · High risk Terminated Jun 8, 2022
Reason Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain elevated levels of yeast and mold as well as the…
Class I · High risk Terminated Jun 7, 2022
Reason Microbial Contamination of Non-Sterile Products.
Class I · High risk Terminated Jun 7, 2022
Reason Microbial Contamination of Non-Sterile Products.
Class I · High risk Terminated Jun 7, 2022
Reason Microbial Contamination of Non-Sterile Products.
Class I · High risk Terminated Jun 7, 2022
Reason Microbial Contamination of Non-Sterile Products
Class I · High risk Terminated May 26, 2022
Reason Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.
Class I · High risk Terminated May 26, 2022
Reason Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.
Class I · High risk Terminated May 26, 2022
Reason Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.
Class I · High risk Terminated May 23, 2022
Reason Superpotent: High Out of specification (OOS) test result for percent label claim (%LC).
Class I · High risk Terminated May 11, 2022
Reason Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.
Class I · High risk Terminated Apr 15, 2022
Reason Subpotent drug
Class I · High risk Terminated Apr 15, 2022
Reason Subpotent drug
Class I · High risk Terminated Apr 12, 2022
Reason Labeling: Missing label on the vial
Class I · High risk Terminated Mar 29, 2022
Reason Chemical Contamination; FDA analysis found product to contain benzene
Class I · High risk Terminated Mar 29, 2022
Reason Chemical Contamination; FDA analysis found product to contain methanol
Class I · High risk Terminated Mar 29, 2022
Reason Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products…
Class I · High risk Terminated Mar 29, 2022
Reason Presence of Particulate Matter: Product was found to contain silica and iron oxide
Class I · High risk Terminated Mar 21, 2022
Reason Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.